2020
DOI: 10.1016/j.jns.2020.116778
|View full text |Cite
|
Sign up to set email alerts
|

Ketamine and nitrous oxide: The evolution of NMDA receptor antagonists as antidepressant agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
40
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 54 publications
(42 citation statements)
references
References 121 publications
(148 reference statements)
0
40
0
1
Order By: Relevance
“…Blood pressure and heart rate increase, while breathing is initially depressed and bronchodilation occurs [60]. The analgesic and anesthetic action of ketamine has been linked to the NMDA receptor blocking activity [61]. Some studies on murine models demonstrated that its pharmacological activity is not determined by the inhibition of the NMDA receptor, but, rather, by a sustained activation of a different glutamate receptor, the AMPA receptor, suggested to be exerted by its metabolite (2R, 6R) -hydroxynorketamine [62].…”
Section: Ketaminementioning
confidence: 99%
See 1 more Smart Citation
“…Blood pressure and heart rate increase, while breathing is initially depressed and bronchodilation occurs [60]. The analgesic and anesthetic action of ketamine has been linked to the NMDA receptor blocking activity [61]. Some studies on murine models demonstrated that its pharmacological activity is not determined by the inhibition of the NMDA receptor, but, rather, by a sustained activation of a different glutamate receptor, the AMPA receptor, suggested to be exerted by its metabolite (2R, 6R) -hydroxynorketamine [62].…”
Section: Ketaminementioning
confidence: 99%
“…The blockage of painful sensitivity occurs at the integumentary and non-visceral level. The osteotendinous, ciliary, corneal, photomotor, pharyngeal and laryngeal reflexes, instead, are preserved; pupillary dilation and vertical or horizontal nystagmus occur [61]. Ketamine has an anticonvulsant action in both animals and humans.…”
Section: Ketaminementioning
confidence: 99%
“…While only a single case report, it represents evidence that a single 1-h inhalation treatment with 50% nitrous oxide may improve and even remit major depressive disorder for more than a month ( 4 ). The mechanism of nitrous oxide’s antidepressant effect is poorly understood and it presumed to involve NMDA-receptor antagonism ( 5 ).…”
Section: Case Reportmentioning
confidence: 99%
“…New insights in the complex etiology of depression might be offered by findings with the use of psychedelics for treatment- (56,69,76,77). Esketamine, the S-enantiomer of ketamine, has been approved by the Food and Drug Administration (FDA) for treatment-resistant depression (78), but ketamine has been and continues to be used offlabel to treat depression too (79). This highlights that serotonergic activity, or even a mono-aminergic activity, is not required for the antidepressant effect of a psychedelic compound, further stressing the need for abandoning the old hypotheses.…”
Section: Psychedelicsmentioning
confidence: 99%